Literature DB >> 18973386

Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation.

Cyril Portmann1, Judith F Blom, Marcel Kaiser, Reto Brun, Friedrich Jüttner, Karl Gademann.   

Abstract

Aerucyclamides C and D were isolated from the cyanobacterium Microcystis aeruginosa PCC 7806, and their structures established by NMR spectroscopy and chemical transformation and degradation. Acidic hydrolysis of aerucyclamide C (CF(3)CO(2)H, H(2)O) resulted in microcyclamide 7806A. This chemical evidence combined with spectroscopic and physical data suggest a structure revision for microcyclamide 7806A, which incorporates an O-acylated Thr ammonium residue instead of the originally proposed methyl oxazoline ring. We have prepared microcyclamide 7806B upon basic and acidic treatment of microcyclamide 7806A, which suggests that both these compounds are hydrolysis products of aerucyclamide C and that the aerucyclamides A-D are the actual metabolites produced via ribosomal peptide synthesis in M. aeruginosa PCC 7806. Antiplasmodial evaluation established submicromolar IC(50) values for aerucyclamide B against Plasmodium falciparum; low micromolar values for aerucyclamide C were found against Trypanosoma brucei rhodesiense. The compounds were selective for the parasites over a cell line of L6 rat myoblasts and are thus considered for further study as antimalarial agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973386     DOI: 10.1021/np800409z

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  31 in total

1.  Linking chemistry and genetics in the growing cyanobactin natural products family.

Authors:  Mohamed S Donia; Eric W Schmidt
Journal:  Chem Biol       Date:  2011-04-22

2.  β-cyclocitral, a grazer defence signal unique to the cyanobacterium Microcystis.

Authors:  Friedrich Jüttner; Susan B Watson; Eric von Elert; Oliver Köster
Journal:  J Chem Ecol       Date:  2010-11-12       Impact factor: 2.626

Review 3.  Genome mining for ribosomally synthesized natural products.

Authors:  Juan E Velásquez; Wilfred A van der Donk
Journal:  Curr Opin Chem Biol       Date:  2010-11-20       Impact factor: 8.822

4.  Microviridin 1777: A Toxic Chymotrypsin Inhibitor Discovered by a Metabologenomic Approach.

Authors:  Simon Sieber; Simone M Grendelmeier; Lonnie A Harris; Douglas A Mitchell; Karl Gademann
Journal:  J Nat Prod       Date:  2020-01-28       Impact factor: 4.050

5.  Expanding the chemical space of synthetic cyclic peptides using a promiscuous macrocyclase from prenylagaramide biosynthesis.

Authors:  Snigdha Sarkar; Wenjia Gu; Eric W Schmidt
Journal:  ACS Catal       Date:  2020-06-17       Impact factor: 13.084

6.  Changes in secondary metabolic profiles of Microcystis aeruginosa strains in response to intraspecific interactions.

Authors:  Enora Briand; Myriam Bormans; Muriel Gugger; Pieter C Dorrestein; William H Gerwick
Journal:  Environ Microbiol       Date:  2015-07-21       Impact factor: 5.491

Review 7.  Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria.

Authors:  Kaarina Sivonen; Niina Leikoski; David P Fewer; Jouni Jokela
Journal:  Appl Microbiol Biotechnol       Date:  2010-02-27       Impact factor: 4.813

Review 8.  Thiazole and oxazole alkaloids: isolation and synthesis.

Authors:  Danilo Davyt; Gloria Serra
Journal:  Mar Drugs       Date:  2010-11-05       Impact factor: 5.118

Review 9.  Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.

Authors:  John A McIntosh; Mohamed S Donia; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-04       Impact factor: 13.423

Review 10.  Lessons learned from the transformation of natural product discovery to a genome-driven endeavor.

Authors:  Caitlin D Deane; Douglas A Mitchell
Journal:  J Ind Microbiol Biotechnol       Date:  2013-10-19       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.